semaglutide in heart failure patients with with preserved ejection fraction and obesity, but without type 2 diabetes, treatment has led to larger reductions in heart failure–related symptoms and physical limitations and greater Cardiovascular outcomes of semaglutide and
Pay in 4 interest-free payments of $7.28 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3

























